Skip to main navigation menu Skip to main content Skip to site footer

Original

Vol. 11 No. 3 (2023): Jurnal Keperawatan Padjadjaran

Self-Measure Office Blood Pressure (SMOBP) and Home Blood Pressure Monitoring (HBPM) for white coat effect diagnosis among hypertension patients

DOI
https://doi.org/10.24198/jkp.v11i3.2343
Submitted
August 2, 2023
Published
2023-12-01

Abstract

Background: Hypertension is a critical factor in the deaths over the world among those who have cardiovascular diseases such as coronary artery disease, stroke, and chronic kidney disease.Purpose: This study aims to investigate the diagnosis capability of the white coat effect in hypertensive patients whose blood pressure was not on target.Methods: This study is an analytical study. Data were collected from 19 uncontrolled hypertension patients at Bang Si Thong health promoting hospital from August to December 2022. The geographic data are presented in the descriptive statistic terms of mean, difference, and standard deviation. The research outcome was analyzed by paired t-test.Results: The research results showed blood pressure measurement by SMOBP was more valuable in terms of statistical significance than Daytime HBPM (134±8.21 vs 125.5±6.74 p<0.001), while it was statistically significantly lower than Office-measured (148.15±10.33 vs 134±8.21 p<0.001), and there were participants whose blood pressures were going as a targeted by SMOBP 55% and HBPM 80%.Conclusion: Self-Measure Office Blood Pressure [SMOBP] can eliminate some of the white coat effect, but it could not be used instead of Home Blood Pressure Monitoring [HBPM] for the diagnosis of white coat hypertension. The SMOBP might be a choice for patients who have the white coat effect in socioeconomically disadvantaged areas.

Article Matrics
Abstract views : 1536 times PDF Downloads: 222

Downloads

Download data is not yet available.

References

  1. Dele-Ojo, B., Kolo, P., Ogunmodede, A., Bello, H., Katibi, I., Omotoso, A., & Dada, S. (2019). Prevalence and predictors of white coat hypertension among newly-diagnosed hypertensive patients in a tertiary health centre in Nigeria. Ethiopian Journal of Health Sciences, 29(4), 431–438. https://doi.org/10.4314/ejhs.v29i4.3
  2. Flint, A. C., Conell, C., Ren, X., Banki, N. M., Chan, S. L., Rao, V. A., ... & Bhatt, D. L. (2019). Effect of systolic and diastolic blood pressure on cardiovascular outcomes. New England Journal of Medicine, 381(3), 243-251. https://doi.org/10.1056/NEJMoa1803180
  3. Franklin, S. S., Thijs, L., Hansen, T. W., O’brien, E., & Staessen, J. A. (2013). White-coat hypertension: New insights from recent studies. Hypertension, 62(6), 982-987. https://doi.org/10.1161/HYPERTENSIONAHA.113.01275
  4. Health Data Centre. The incidence rate of hypertension per population 2021 (2021).
  5. MacDonald M.B., Laing G.P., Wilson M.P., and Wilson T. W. (1999) Prevalence and predictors of white-coat response in patients with treated hypertension. CMAJ, 161(3), 265-9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1230502/
  6. Myers, M. G., Godwin, M., Dawes, M., Kiss, A., Tobe, S. W., & Kaczorowski, J. (2010). Measurement of blood pressure in the office: Recognizing the problem and proposing the solution. Hypertension, 55(2), 195-200. https://doi.org/10.1161/HYPERTENSIONAHA.109.141879
  7. O’Brien E, Parati G, Stergiou G, et al. (2013). European society of hypertension position paper on ambulatory blood pressure monitoring. J Hypertension, 31, 1731–1767. https://doi.org/10.1097/HJH.0b013e328363e964
  8. O’Brien, E., Coats, A., Owens, P., Petrie, J., Padfield, P. L., Littler, W. A., ... & Mee, F. (2000). Use and interpretation of ambulatory blood pressure monitoring: Recommendations of the British Hypertension Society. Bmj, 320(7242), 1128-1134. https://doi.org/10.1136/bmj.320.7242.1128
  9. Filipovský, J., Seidlerová, J., Kratochvíl, Z., Karnosová, P., Hronová, M., & Mayer Jr, O. (2016). Automated compared to manual office blood pressure and to home blood pressure in hypertensive patients. Blood pressure, 25(4), 228-234. https://doi.org/10.3109/08037051.2015.1134086
  10. Natale, P., Ni, J. Y., Martinez-Martin, D., Kelly, A., Chow, C. K., Thiagalingam, A., ... & Jaure, A. (2023). Perspectives and experiences of self-monitoring of blood pressure among patients with hypertension: A systematic review of qualitative studies. American Journal of Hypertension, 36(7), 372-384. https://doi.org/10.1093/ajh/hpad021
  11. Ramli, A. S., Halmey, N., & Teng, C. L. (2008). White coat effect and white coat hypertension: One and the same?. Malaysian family physician: the official journal of the Academy of Family Physicians of Malaysia, 3(3), 158. PMID: 25606143; PMCID: PMC4170363.
  12. Raymond R. Townsend. (2020). Out-of-office blood pressure monitoring: A comparison of ambulatory blood pressure monitoring and home (self) monitoring of blood pressure. Hypertension, 76(6), 1667-1673. https://doi.org/10.1161/HYPERTENSIONAHA.120.14650
  13. Salazar, M. R., Espeche, W. G., Stavile, R. N., Balbín, E., Leiva Sisnieguez, B. C., Leiva Sisnieguez, C. E., ... & Carbajal, H. A. (2018). Could self-measured office blood pressure be a hypertension screening tool for limited-resources settings?. Journal of Human Hypertension, 32(6), 415-422. https://doi.org/10.1038/s41371-018-0057-y
  14. Stanaway, J. D., Afshin, A., Gakidou, E., Lim, S. S., Abate, D., Abate, K. H., ... & Bleyer, A. (2018). Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 392(10159), 1923-1994. https://doi.org/10.1016/S0140-6736(18)32225-6
  15. Sukonthasarn Apichard, Kunjara Na Ayudhya Rapeephon, Sitthisook Surapun, Chattranukulchai Pairoj, Roubsanthhisuk Weranuj, Saengwattanaroj Somkiat, et al. (2019) Thai Guidelines on The Treatment of Hypertension. 1st ed. Chiangmai: Trick Think; 2562. http://www.thaihypertension.org/files/442.HT%20guideline%202019.with%20watermark.pdf
  16. Tsai TY, Cheng HM, Chuang SY, Chia YC, Soenarta AA, Minh H Van, et al. (2021) Isolated systolic hypertension in Asia. J Clin Hypertens (Greenwich), 23(3), 467–74. https://doi.org/10.1111/jch.14111
  17. The SPRINT Research Group. (2015). A randomized trial of intensive versus standard blood-pressure control. New England Journal of Medicine, 373(22), 2103-2116. https://doi.org/ 10.1056/NEJMoa1511939
  18. Unger, T., Borghi, C., Charchar, F., Nadia, A. K., Neil, R. P., Prabhakaran, D., ... & Aletta, E. S. (2020). 2020 international society of hypertension global hypertension practice guidelines. Journal of Hypertension, 38(6), 982-1004. https://dx.doi.org/10.1097/HJH.0000000000002453
  19. Zhou B, Perel P, Mensah GA, Ezzati M. (2021) Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol, 18(11), 785–802. https://doi.org/10.1038/s41569-021-00559-8
  20. Zhou B, Carrillo-Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA, et al. (2021) Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. Lancet, 398(10304). https://doi.org/10.1016/S0140-6736(21)01330-1